Prof. Charles Stewart III and Ben Adida PhD ’06 speak with Fast Company reporter Spenser Mestel about how to restore the public’s faith in voting technology. Adida discusses his work launching VotingWorks, a non-profit focused on building voting machines. VotingWorks is “unique among the legacy voting technology vendors," writes Mestel. “The group has disclosed everything, from its donors to the prices of its machines.”
Prof. Feng Zhang has been named to STAT’s 2024 STATUS List, which highlights the leaders shaping the future of health and life sciences, reports Dialynn Dwyer for Boston.com. “Among the companies he’s co-founded is Editas Medicine, which as of late 2023 was now the official holder of patent rights to the CRISPR-Cas9 gene editing tool used in the sickle cell therapy Casgevy, and Aera Therapeutics, which in February 2023 raised $193 million in venture funding to develop protein nanoparticles as a way of delivering gene editing,” Dwyer writes.
Los Angeles Times reporter Gustavo Arellano spotlights Democratic Senator Alex Padilla ’94 and his political career in California. Padilla “realized the only way to make things better for the Valley’s growing Latino community, in an era of anti-immigrant sentiment across California, was to elect politicians who looked like them,” writes Arellano.
Former postdoc Leah Ellis speaks with GBH All Things Considered host Arun Rath about Sublime Systems, an MIT startup she co-founded that aims to produce carbon-free cement to combat climate change. “Sublime Systems and this technology spun out of my postdoctoral work at MIT,” says Ellis. “My co-founder and I are both electric chemists, so we have experience with battery technologies and electrochemical systems. Our idea was thinking about how we might use renewable energy—which we know has become more abundant, inexpensive and available—to eliminate the CO2 emissions from cement.”
Researchers at MIT and elsewhere have developed a machine-learning model that can identify which drugs should not be taken together, reports Politico. “The researchers built a model to measure how intestinal tissue absorbed certain commonly used drugs,” they write. “They then trained a machine-learning algorithm based on their new data and existing drug databases, teaching the new algorithm to predict which drugs would interact with which transporter proteins.”
Research scientist Beth Pollack speaks with the New York Times’ Pam Belluck about her work studying the mechanisms of long Covid-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). “Experts said the study, which is the N.I.H’s first detailed look at ME/CFS, should be considered only one step in understanding the condition, its severity and potential remedies,” explains Belluck. “We must advance the field towards research on treatment,” says Pollack.
Prof. Erik Demaine speaks with Boston Globe reporter Cate McQuaid about how combining the art of origami with computer science has enhanced his work in both fields. “We get stuck on a science problem and that inspires a new sculpture, or we get stuck trying to build a sculpture,” says Demaine, “and that leads to new science.”
Prof. Anantha Chandrakasan, dean of the School of Engineering, has been named MIT’s first chief innovation and strategy officer, reports Supriya Singh for New India Abroad. “In his new role, Chandrakasan will work closely with MIT president Sally Kornbluth, key stakeholders across MIT, as well as external partners, to launch initiatives and new collaborations in support of strategic priorities,” explains Singh.
Prof. Paulo Lozano speaks with Kaity Kline of NPR’s Morning Edition about the space stations of the future and how NASA collaborating with private companies on the development of the next iteration of the International Space Station could spur new technological advancements. “Once you have entrepreneurship and you have a commercial interest, that accelerates technology development,” says Lozano.
Omar Abudayyeh '12, PhD '18 and Jonathan Gootenberg '13 speak with Robert Weisman at The Boston Globe about their deep-rooted working relationship, which began as undergraduates at MIT and has gone on to include joint appointments at the McGovern and Broad Institutes and multiple startups. “Science is difficult, and it’s great to have someone to do it with,” said Gootenberg. “You got to work with people you enjoy hanging out with.”
Prof. Xuanhe Zhao speaks with Amerigo Allegretto of AuntMinnie.com about his work developing a new ultrasound sticker that can measure the stiffness of internal organs and could one day be used for early detection and diagnosis of disease. “Due to the huge potential of measuring the rigidity of deep internal organs, we believe we can use this to monitor organ health,” Zhao explains.
MIT has been named to the number two spot in Times Higher Education’s world reputation rankings, reports Times Higher Education. MIT is “dedicated to the teaching of science and technology. The sheer number of Nobel laureates affiliated with the institution – an impressive 101 – reveals the caliber of MIT graduates,” Times Higher Education notes. “Scientific discoveries and technological advances to come out of the college include the first chemical synthesis of penicillin, the development of radar, the discovery of quarks and the invention of magnetic core memory, which aided the development of digital computers.”
MIT researchers have developed new technology that allows vaccines to be directly inserted into the lymph nodes to target two of the most common mutations in the KRAS gene, which cause roughly one third of all cancers, reports Jaimie Seaton for Scientific American. “The team modified the small vaccine components to include a fatty acid, which enables the vaccine to effectively hitch a ride on albumin, a common protein found throughout the body,” explains Seaton. “Albumin serves as a molecular shuttle bus, with pockets on its surface where fatty acids can bind to it.”
Sublime Systems, an MIT startup, is developing new technology to fully decarbonize the cement manufacturing process, reports Adele Peters for Fast Company. “Instead of using heat to break down rocks for cement, the startup uses chemistry to dissolve them, and then blends the components back together into what it calls ‘Sublime Cement,’” explains Peters. “The process can replace limestone with other minerals, including rocks found at high volumes in industrial waste, so it’s also possible to eliminate the emissions from limestone.”
Corey Jaskolski SM '02 founded Synthetaic, a software company that uses AI to “automate the analysis of large datasets, namely satellite imagery and video, not containing labels,” reports Kyle Wiggers for TechCrunch. “Synthetaic’s technology offers a transformative approach to AI model training and creation, addressing the critical needs of technical decision makers,” says Jaskolski.